SEC Filing Summary: Bristol-Myers Squibb Co. (8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Bristol-Myers Squibb Company on October 20, 2005, regarding an event that occurred on October 14, 2005. The filing addresses corporate governance changes specifically related to the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific corporate event and does not contain financial performance data.
Material Changes
The material change reported is the resignation of Ellen V. Futter from the Company's Board of Directors. Her resignation is effective as of December 31, 2005.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the notification of the director's departure.
Key Facts for Investor Verification
- Ellen V. Futter notified the Company of her resignation on October 14, 2005.
- The resignation from the Board of Directors is effective December 31, 2005.
- No financial data or operational metrics are included in this specific filing.